Recurrence of Hyperprolactinemia after Withdrawal of Long-Term Cabergoline Therapy
AUTOR(ES)
Kharlip, J.
FONTE
The Endocrine Society
RESUMO
Context: Recurrence of hyperprolactinemia after cabergoline withdrawal ranges widely from 36 to 80%. The Pituitary Society recommends withdrawal of cabergoline in selected patients.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2708963Documentos Relacionados
- Long-Term Oxygen Therapy
- Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department
- Long-Term Intramuscular Prednisolone Therapy
- Sites of recurrence and long-term results of redo surgery.
- Case Reports: Two Femoral Insufficiency Fractures after Long-term Alendronate Therapy
